- aTyr Pharma, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – ATYR Business Wire
- aTyr hits record low as lung disease drug fails in late-stage trial Reuters
- aTyr Pharma Announces Topline Results from Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis Yahoo Finance
- aTyr flunks phase 3 lung disease trial, deflating stock, but still plans talks with FDA Fierce Biotech
- Efzofitimod Fails to Meet Primary End Point in Phase 3 Pulmonary Sarcoidosis Trial HCPLive
Source link
